Hyperammonemic encephalopathy and fibrolamellar hepatocellular carcinoma;Encefalopatía hiperamoniémica y hepatocarcinoma fibrolamelar

Medicina (Argentina)

Volumn 72, Issue 5, 2012, Pages 425-427

  Berger, Cintia ^a   Dimant, Pablo ^a   Hermida, Laura ^a   Paulin, Francisco ^a   Pereyra, Matías ^b   Tejo, Mariana ^b  

^a Servicio de Clinica Medica de Hospital Nacional Professor Dr Alejandro Posadas   (Argentina)

^b HOSPITAL JUAN A FERNÁNDEZ   (Argentina)

Author keywords

Fibrolamellar carcinoma; Hyperammonemic encephalopathy

Indexed keywords

ADULT; ARTICLE; BRAIN DISEASE; CASE REPORT; FEMALE; FIBROLAMELLAR HEPATOCELLULAR CARCINOMA; HUMAN; HYPERAMMONEMIA; HYPERAMMONEMIC ENCEPHALOPATHY; LIVER CELL CARCINOMA;

CARCINOMA, HEPATOCELLULAR; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; HYPERAMMONEMIA; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; ULTRASONOGRAPHY, DOPPLER; YOUNG ADULT;

EID: 84867949165     PISSN: 00257680     EISSN: 16699106     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Dalmau J, Rosenfeld MR, Paraneoplastic syndromes of the CNS. Lancet Neurol 2008; 7: 327-340.
2. Sethi S, Tageja N, Singh J, et al. Hyperammonemic encephalopathy: a rare presentation of fibrolamellar hepatocellular carcinoma. Am J Med Sci 2009; 338: 522-524.
3. Edmonson HA. Differencial diagnosis of tumors and tumorlike lesions of liver in infancy and childhood. Arch Dis Child 1956; 1: 168-186.
4. Hamilton SR, Aaltonen LA (ed). Tumors of the liver and intrahepatic bile ducts. In: Pathology and genetics of the digestive system. Lyon: IARC Press; 2000, p 159-172.
5. Stephen C, Ward, MD, Waxman S. Fibrolamellar Carcinoma: A review with focus on genetics and comparison to other malignant primary liver tumors. Semin Liver Dis 2011; 31: 61-70.
6. Craig JR, Peters RL, Edmonson HA, Omata M. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinic pathologic features. Cancer 1980; 46: 372-379.
7. Waxman S, Gilbert HS. A tumor-related vitamin B12 binding protein in adolescent hepatoma. N Engl J Med 1973; 289: 1053-1056.
8. Waxman S, Liu CK, Schreiber C, Helson L.The clinical and physiological implications of hepatoma B12-binding proteins. Cancer Res 1977; 37: 1908-1914.
9. Stipa F, Yoon SS, Liau KH, et al. Outcome of patients with fibrolamellar hepatocellular carcinoma. Cancer 2006; 106: 1331-1338.
10. Epstein Be, Pajak TF, Haulk TL, Herpst JM, Order SE, Abrams RA. Metastatic nonresectable fibrolamellar hepatoma: prognostic features and natural history. Am J Clin Oncol 1999; 22: 22-28.